JAID/JSC Guidelines for Clinical Management of Infectious Disease 2015 − Urinary tract infection/male genital infection

Yamamoto, Shingo; Ishikawa, Kiyohito; Hayami, Hiroshi; Nakamura, Tadahiro; Miyairi, Isao; Hoshino, Tadashi; Hasui, Masafumi; Tanaka, Kazushi; Kiyota, Hiroshi; Arakawa, Soichi

doi:10.1016/j.jiac.2017.02.002

Cited by 50 publications

(49 citation statements)

References 128 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…they are on October 30, 2020 by guest http://aac.asm.org/ Downloaded from considered to have complicated UTI (8,9), which may provide some explanation. Notably, Japanese guidelines state that there is a high rate of E. coli resistance to fluoroquinolones in postmenopausal women with UTIs; consequently, penicillins or cephalosporins recommended first-line treatment options (10).…”

Section: Resultsmentioning

confidence: 99%

“…Treatment of community-acquired uUTI remains largely empirical and diagnosis is made based on the presence of characteristic lower urinary tract symptoms (8)(9)(10)(11). With respect to specific antimicrobial therapies, US and international guidelines recommend first-line treatment with nitrofurantoin, trimethoprim-sulfamethoxazole (TMS) (according to local E. coli resistance patterns), fosfomycin or pivmecillinam (8,9).…”

Section: Downloaded Frommentioning

confidence: 99%

See 1 more Smart Citation

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review

Stapleton

Wagenlehner

Mulgirigama³

et al. 2020

Antimicrob Agents Chemother

View full text Add to dashboard Cite

Antibiotic resistance represents a threat to public health, and uncomplicated urinary tract infections (uUTIs) are an example of this concern. This systematic review (PROSPERO ID: CRD42020156674) is the first to determine the prevalence of E. coli resistance to fluoroquinolones in women with community-acquired uUTI. PubMed and Embase searches were conducted, 38 studies fulfilled eligibility criteria and were included in the systematic review. Within Europe, ciprofloxacin resistance in E. coli isolates varied between countries, and increased in some between 2006–8 and 2014–16, specifically in the UK (0.5% to 15.3%), Germany (8.7% to 15.1%), and Spain (22.9% to 30.8%), although methodologies and settings were often not comparable. In Asia there was a substantial increase in ciprofloxacin resistance during 2008–14 from 25% to more than 40%. In North America, resistance to ciprofloxacin also increased between 2008–2017, from 4% to 12%. Data exploring different age groups did not show a consistent relationship with resistance, whereas two studies found that fluoroquinolone resistance was higher in postmenopausal women than premenopausal women. One study indicated a link between fluoroquinolone resistance and uUTI recurrence. These findings may have implications for empirical treatment of uUTI with fluoroquinolones globally, but more data are needed to fully understand regional situations and impact on patient management.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Downloaded Frommentioning

confidence: 99%

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review

Stapleton

Wagenlehner

Mulgirigama³

et al. 2020

Antimicrob Agents Chemother

View full text Add to dashboard Cite

show abstract

“…Approximately 250,000 cases of pyelonephritis occur each year in the US ( 1 ). The management guidelines for urinary tract infections in the US and Japan recommend that patients with mild, uncomplicated pyelonephritis be treated in an outpatient clinic ( 2 , 3 ). However, previous studies have reported that 15-32% of pyelonephritis cases were complicated with bacteremia ( 4 , 5 ).…”

Section: Introductionmentioning

confidence: 99%

Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis

et al. 2018

View full text Add to dashboard Cite

Objective The aim of this study was to identify predictive factors for bacteremia conveniently and quickly among outpatients diagnosed with pyelonephritis. Patients All patients who were diagnosed with pyelonephritis at the outpatient clinic in the Department of General Medicine of Juntendo University Hospital from April 1, 2008, to June 30, 2015, were enrolled. Patients from whom blood cultures had not been taken were excluded. Methods Clinical information was extracted from medical charts. Factors potentially predictive of bacteremia were analyzed using a t-test and Fisher's exact test, followed by a multivariable logistic regression model analysis. Results Blood cultures were drawn from 116 patients, and 25 (22%) presented with bacteremia. A multivariate analysis with the age, chills, platelet count and urine nitrite test results revealed that older age, positive urinary nitrite test results and chills tended to be associated with bacteremia, respectively. [older age: unit odds ratio (OR) 1.02, p=0.052, 95% confidence interval (CI) 1.00-1.05, positive urinary nitrite test findings: OR 2.5, p=0.092, 95% CI 0.86-7.7, chills: OR 2.5, p=0.096, 95% CI 0.84-7.65]. The area under the receiver operating characteristic (ROC) curve of this model was 0.77. Regardless of age, positive urinary nitrite test findings were significantly associated with bacteremia (OR 3.1, p=0.033, 95% CI 1.1-9.2), and chills tended to be associated with bacteremia (OR 2.7, p=0.07, 95% CI 0.93-7.9) The area under the ROC curve of this model was 0.75. Conclusion Bacteremia should be considered in pyelonephritis patients with rapidly assessable factors in outpatient clinic. In particular, a model including a urinary nitrite test has the potential to aid in the prediction of bacteremia.

show abstract

“…Diagnostic imaging using ultrasound is recommended in cases of acute suppurative cholangitis, and reaching a definitive diagnosis via CT or magnetic resonance cholangiopancreatography (MRCP) is important when local complications such as perforation or abscess formation are suspected [ 37 ]. In cases of sepsis caused by urinary tract infection (caused by a kidney stone or indwelling catheter) or infection of the male genitalia, the source of infection can be identified through abdominal ultrasonography or abdominal CT examination [ 38 ]. Although kidney, ureter, and bladder simple X-ray image (KUB) is useful in diagnosing conditions such as kidney stones, performing a CT scan is necessary for evaluation of perinephric inflammation.…”

Section: Cq3: Imaging Diagnosesmentioning

confidence: 99%

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)

et al. 2018

View full text Add to dashboard Cite

Background and purposeThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in February 2017 and published in the Journal of JSICM, [2017; Volume 24 (supplement 2)] 10.3918/jsicm.24S0001 and Journal of Japanese Association for Acute Medicine [2017; Volume 28, (supplement 1)] http://onlinelibrary.wiley.com/doi/10.1002/jja2.2017.28.issue-S1/issuetoc.This abridged English edition of the J-SSCG 2016 was produced with permission from the Japanese Association of Acute Medicine and the Japanese Society for Intensive Care Medicine.MethodsMembers of the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine were selected and organized into 19 committee members and 52 working group members. The guidelines were prepared in accordance with the Medical Information Network Distribution Service (Minds) creation procedures. The Academic Guidelines Promotion Team was organized to oversee and provide academic support to the respective activities allocated to each Guideline Creation Team. To improve quality assurance and workflow transparency, a mutual peer review system was established, and discussions within each team were open to the public. Public comments were collected once after the initial formulation of a clinical question (CQ) and twice during the review of the final draft. Recommendations were determined to have been adopted after obtaining support from a two-thirds (> 66.6%) majority vote of each of the 19 committee members.ResultsA total of 87 CQs were selected among 19 clinical areas, including pediatric topics and several other important areas not covered in the first edition of the Japanese guidelines (J-SSCG 2012). The approval rate obtained through committee voting, in addition to ratings of the strengths of the recommendation, and its supporting evidence were also added to each recommendation statement. We conducted meta-analyses for 29 CQs. Thirty-seven CQs contained recommendations in the form of an expert consensus due to insufficient evidence. No recommendations were provided for five CQs.ConclusionsBased on the evidence gathered, we were able to formulate Japanese-specific clinical practice guidelines that are tailored to the Japanese context in a highly transparent manner. These guidelines can easily be used not only by specialists, but also by non-specialists, general clinicians, nurses, pharmacists, clinical engineers, and other healthcare professionals.Electronic supplementary materialThe online version of this article (10.1186/s40560-017-0270-8) contains supplementary material, which is available to authorized users.

show abstract

JAID/JSC Guidelines for Clinical Management of Infectious Disease 2015 − Urinary tract infection/male genital infection

Cited by 50 publications

References 128 publications

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review

Useful Predictive Factors for Bacteremia among Outpatients with Pyelonephritis

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)

Contact Info

Product

Resources

About